Literature DB >> 22926851

Familial cortical myoclonus with a mutation in NOL3.

Jonathan F Russell1, Jamie L Steckley, Giovanni Coppola, Angelika F G Hahn, MacKenzie A Howard, Zachary Kornberg, Alden Huang, Seyed M Mirsattari, Barry Merriman, Eric Klein, Murim Choi, Hsien-Yang Lee, Andrew Kirk, Carol Nelson-Williams, Gillian Gibson, Scott C Baraban, Richard P Lifton, Daniel H Geschwind, Ying-Hui Fu, Louis J Ptáček.   

Abstract

OBJECTIVE: Myoclonus is characterized by sudden, brief involuntary movements, and its presence is debilitating. We identified a family suffering from adult onset, cortical myoclonus without associated seizures. We performed clinical, electrophysiological, and genetic studies to define this phenotype.
METHODS: A large, 4-generation family with a history of myoclonus underwent careful questioning, examination, and electrophysiological testing. Thirty-five family members donated blood samples for genetic analysis, which included single nucleotide polymorphism mapping, microsatellite linkage, targeted massively parallel sequencing, and Sanger sequencing. In silico and in vitro experiments were performed to investigate functional significance of the mutation.
RESULTS: We identified 11 members of a Canadian Mennonite family suffering from adult onset, slowly progressive, disabling, multifocal myoclonus. Somatosensory evoked potentials indicated a cortical origin of the myoclonus. There were no associated seizures. Some severely affected individuals developed signs of progressive cerebellar ataxia of variable severity late in the course of their illness. The phenotype was inherited in an autosomal dominant fashion. We demonstrated linkage to chromosome 16q21-22.1. We then sequenced all coding sequence in the critical region, identifying only a single cosegregating, novel, nonsynonymous mutation, which resides in the gene NOL3. Furthermore, this mutation was found to alter post-translational modification of NOL3 protein in vitro.
INTERPRETATION: We propose that familial cortical myoclonus is a novel movement disorder that may be caused by mutation in NOL3. Further investigation of the role of NOL3 in neuronal physiology may shed light on neuronal membrane hyperexcitability and pathophysiology of myoclonus and related disorders.
Copyright © 2012 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22926851      PMCID: PMC3431191          DOI: 10.1002/ana.23666

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  29 in total

1.  Classification of progressive myoclonus epilepsies and related disorders. Marseille Consensus Group.

Authors: 
Journal:  Ann Neurol       Date:  1990-07       Impact factor: 10.422

Review 2.  Familial adult myoclonic epilepsy (FAME).

Authors:  Eiichiro Uyama; Ying-Hui Fu; Louis J Ptácek
Journal:  Adv Neurol       Date:  2005

3.  Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays.

Authors:  Seyedmehdi Shojaee; Farzad Sina; Setareh Sadat Banihosseini; Mohammad Hossein Kazemi; Reza Kalhor; Gholam-Ali Shahidi; Hossein Fakhrai-Rad; Mostafa Ronaghi; Elahe Elahi
Journal:  Am J Hum Genet       Date:  2008-06       Impact factor: 11.025

4.  ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases.

Authors:  T Koseki; N Inohara; S Chen; G Núñez
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

5.  Discovery of common Asian copy number variants using integrated high-resolution array CGH and massively parallel DNA sequencing.

Authors:  Hansoo Park; Jong-Il Kim; Young Seok Ju; Omer Gokcumen; Ryan E Mills; Sheehyun Kim; Seungbok Lee; Dongwhan Suh; Dongwan Hong; Hyunseok Peter Kang; Yun Joo Yoo; Jong-Yeon Shin; Hyun-Jin Kim; Maryam Yavartanoo; Young Wha Chang; Jung-Sook Ha; Wilson Chong; Ga-Ram Hwang; Katayoon Darvishi; Hyeran Kim; Song Ju Yang; Kap-Seok Yang; Hyungtae Kim; Matthew E Hurles; Stephen W Scherer; Nigel P Carter; Chris Tyler-Smith; Charles Lee; Jeong-Sun Seo
Journal:  Nat Genet       Date:  2010-04-04       Impact factor: 38.330

6.  Alteration of caspases and other apoptosis regulatory proteins in Down syndrome.

Authors:  T Gulesserian; E Engidawork; B C Yoo; N Cairns; G Lubec
Journal:  J Neural Transm Suppl       Date:  2001

Review 7.  Myoclonus: current concepts and recent advances.

Authors:  John N Caviness; Peter Brown
Journal:  Lancet Neurol       Date:  2004-10       Impact factor: 44.182

8.  Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.

Authors:  Jesper V Olsen; Michiel Vermeulen; Anna Santamaria; Chanchal Kumar; Martin L Miller; Lars J Jensen; Florian Gnad; Jürgen Cox; Thomas S Jensen; Erich A Nigg; Søren Brunak; Matthias Mann
Journal:  Sci Signal       Date:  2010-01-12       Impact factor: 8.192

9.  Electrophysiological features of myoclonus-dystonia.

Authors:  Jie-Yuan Li; Danny I Cunic; Guillermo Paradiso; Carolyn Gunraj; Pramod K Pal; Anthony E Lang; Robert Chen
Journal:  Mov Disord       Date:  2008-10-30       Impact factor: 10.338

Review 10.  Electrophysiological studies of myoclonus.

Authors:  Hiroshi Shibasaki; Mark Hallett
Journal:  Muscle Nerve       Date:  2005-02       Impact factor: 3.217

View more
  7 in total

Review 1.  Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencing.

Authors:  Marie Coutelier; Giovanni Stevanin; Alexis Brice
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

Review 2.  Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease.

Authors:  Stefanie Gerstberger; Markus Hafner; Manuel Ascano; Thomas Tuschl
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

3.  Placental DNA Methylation Related to Both Infant Toenail Mercury and Adverse Neurobehavioral Outcomes.

Authors:  Jennifer Z J Maccani; Devin C Koestler; Barry Lester; E Andrés Houseman; David A Armstrong; Karl T Kelsey; Carmen J Marsit
Journal:  Environ Health Perspect       Date:  2015-03-06       Impact factor: 9.031

4.  Screening of mutations in NOL3 in a myoclonic syndromes series.

Authors:  A Macerollo; N E Mencacci; R Erro; C Cordivari; M J Edwards; N W Wood; Kailash P Bhatia
Journal:  J Neurol       Date:  2014-08-20       Impact factor: 4.849

Review 5.  Familial Cortical Myoclonic Tremor and Epilepsy, an Enigmatic Disorder: From Phenotypes to Pathophysiology and Genetics. A Systematic Review.

Authors:  Tom van den Ende; Sarvi Sharifi; Sandra M A van der Salm; Anne-Fleur van Rootselaar
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-01-23

6.  KMT2B Is Selectively Required for Neuronal Transdifferentiation, and Its Loss Exposes Dystonia Candidate Genes.

Authors:  Giulia Barbagiovanni; Pierre-Luc Germain; Michael Zech; Sina Atashpaz; Pietro Lo Riso; Agnieszka D'Antonio-Chronowska; Erika Tenderini; Massimiliano Caiazzo; Sylvia Boesch; Robert Jech; Bernhard Haslinger; Vania Broccoli; Adrian Francis Stewart; Juliane Winkelmann; Giuseppe Testa
Journal:  Cell Rep       Date:  2018-10-23       Impact factor: 9.423

Review 7.  Role of apoptosis repressor with caspase recruitment domain (ARC) in cancer.

Authors:  Zhongjie Yu; Qi Li; Yi An; Xiatian Chen; Ziqian Liu; Zhe Li; Jinning Gao; Lynn Htet Htet Aung; Peifeng Li
Journal:  Oncol Lett       Date:  2019-10-11       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.